[10-Q] Amrize Ltd Quarterly Earnings Report
Amrize Ltd (AMRZ) reported Q3 2025 results. Revenue rose to $3,675 million from $3,446 million, while diluted EPS was $0.98 versus $1.00 a year ago. Gross profit improved to $1,086 million, but operating income declined to $778 million as selling, general and administrative expenses increased to $312 million.
By segment, Building Materials revenue was $2,774 million with Segment Adjusted EBITDA of $902 million, and Building Envelope revenue was $901 million with Segment Adjusted EBITDA of $217 million. For the first nine months, revenue was $8,976 million and diluted EPS was $1.60.
Following its June 2025 spin-off from Holcim, Amrize reshaped its capital structure: long-term debt was $4,932 million, including new senior notes issued earlier in 2025 and exchanged notes, and commercial paper outstanding of $547 million. Cash and cash equivalents were $826 million. Operating cash flow for the nine months was $404 million, with capital expenditures of $631 million. Shares outstanding were 553,082,069 as of September 30, 2025.
Amrize Ltd (AMRZ) ha riportato i risultati del Q3 2025. Le entrate sono aumentate a 3.675 milioni di dollari da 3.446 milioni, mentre l'EPS diluito è stato 0,98 dollari contro 1,00 dollaro dell'anno precedente. Il profitto lordo è migliorato a 1.086 milioni, ma l'utile operativo è diminuito a 778 milioni poiché le spese di vendita, generali e amministrative sono aumentate a 312 milioni.
Per segmento, le entrate dei Building Materials sono state 2.774 milioni con EBITDA rettificato di segmento di 902 milioni, e le entrate del Building Envelope sono state 901 milioni con EBITDA rettificato di segmento di 217 milioni. Nei primi nove mesi, le entrate sono state 8.976 milioni e l'EPS diluito è stato 1,60.
Dopo lo spin-off da Holcim avvenuto nel giugno 2025, Amrize ha ristrutturato la propria struttura del capitale: il debito a lungo termine ammontava a 4.932 milioni, inclusi i nuovi senior notes emessi all'inizio del 2025 e note scambiate, e carta commerciale in circolazione per 547 milioni. La cassa e gli equivalenti di cassa ammontavano a 826 milioni. Il flusso di cassa operativo nei nove mesi è stato di 404 milioni, con investimenti in capitale di 631 milioni. Le azioni in circolazione ammontavano a 553.082.069 al 30 settembre 2025.
Amrize Ltd (AMRZ) informó resultados del tercer trimestre de 2025. Los ingresos aumentaron a 3.675 millones de dólares desde 3.446 millones, mientras que el BPA diluido fue de 0,98 dólares frente a 1,00 dólar hace un año. El beneficio bruto mejoró a 1.086 millones, pero el ingreso operativo disminuyó a 778 millones ya que los gastos de venta, generales y administrativos aumentaron a 312 millones.
Por segmento, los ingresos de Building Materials fueron de 2.774 millones con EBITDA ajustado por segmento de 902 millones, y los ingresos de Building Envelope fueron de 901 millones con EBITDA ajustado por segmento de 217 millones. En los primeros nueve meses, los ingresos fueron de 8.976 millones y el BPA diluido fue de 1,60.
Tras su spin-off de Holcim en junio de 2025, Amrize reestructuró su estructura de capital: la deuda a largo plazo fue de 4.932 millones, incluyendo las nuevas notas senior emitidas a principios de 2025 y notas canjeadas, y el papel comercial en circulación de 547 millones. La liquidez en caja y equivalentes fue de 826 millones. El flujo de efectivo operativo de los nueve meses fue de 404 millones, con gastos de capital de 631 millones. Las acciones en circulación eran 553.082.069 al 30 de septiembre de 2025.
Amrize Ltd (AMRZ)가 2025년 3분기 실적을 발표했습니다. 매출은 3,675백만 달러에서 3,446백만 달러에서 증가했고, 희석된 주당순이익(EPS)은 지난해 같은 기간의 1.00달러에서 0.98달러로 감소했습니다. 총이익은 1,086백만원으로 개선되었으나 영업이익은 778백만원으로 감소했고 매출원가 및 일반관리비가 312백만원 상승했습니다.
섹터별로 Building Materials 매출은 2,774백만 달러, 세그먼트 조정 EBITDA는 902백만 달러였고, Building Envelope 매출은 901백만 달러로 세그먼트 조정 EBITDA는 217백만 달러였습니다. 처음 9개월 동안 매출은 8,976백만 달러였고 희석된 EPS는 1.60달러였습니다.
2025년 6월 Holcim으로부터의 분사 이후, Amrize는 자본구조를 재구성했습니다: 장기부채는 4,932백만 달러였으며, 2025년 초에 발행된 신규 상환우선채 및 교환채, 그리고 유통 중인 상업어음 54.7백만 달러가 포함되었습니다. 현금 및 현금성자산은 8.26억 달러였습니다. 9개월간 영업활동현금흐름은 4.04억 달러, 자본지출은 6.31억 달러였습니다. 2025년 9월 30일 기준 발행주식수는 5억 5,308만 2,069주였습니다.
Amrize Ltd (AMRZ) a publié ses résultats du T3 2025. Le chiffre d'affaires a augmenté à 3 675 millions de dollars contre 3 446 millions, tandis que le BPA dilué était de 0,98 dollar contre 1,00 dollar l'an dernier. La marge brute s'est améliorée à 1 086 millions, mais le résultat opérationnel a diminué à 778 millions, les dépenses de vente, générales et administratives augmentant à 312 millions.
Par segment, le chiffre d'affaires Building Materials était de 2 774 millions, avec un EBITDA ajusté par segment de 902 millions, et le chiffre d'affaires Building Envelope était de 901 millions, avec un EBITDA ajusté par segment de 217 millions. Pour les neuf premiers mois, le chiffre d'affaires était de 8 976 millions et le BPA dilué était de 1,60.
Suite à sa scission de Holcim en juin 2025, Amrize a restructuré sa structure de capital: la dette à long terme était de 4 932 millions, incluant les nouvelles obligations senior émises au début de 2025 et des notes échangées, et le papier commercial en circulation de 547 millions. La trésorerie et les équivalents de trésorerie s'élevaient à 826 millions. Le flux de trésorerie opérationnel sur neuf mois était de 404 millions, avec des dépenses d'investissement de 631 millions. Le nombre d'actions en circulation était de 553 082 069 au 30 septembre 2025.
Amrize Ltd (AMRZ) meldete die Ergebnisse für das Q3 2025. Der Umsatz stieg auf 3.675 Mio. USD von 3.446 Mio. USD, während der verwässerte Gewinn je Aktie (EPS) 0,98 USD betrug gegenüber 1,00 USD im Vorjahr. Die Bruttogewinnmarge verbesserte sich auf 1.086 Mio. USD, aber das Operating Income ging auf 778 Mio. USD zurück, da die Vertriebs-, Allgemeine und Verwaltungskosten auf 312 Mio. USD stiegen.
Nach Segmenten betrachtet, belief sich der Umsatz von Building Materials auf 2.774 Mio. USD mit einem segmentbezogenen EBITDA von 902 Mio. USD, und der Umsatz von Building Envelope betrug 901 Mio. USD mit einem segmentbezogenen EBITDA von 217 Mio. USD. In den ersten neun Monaten betrug der Umsatz 8.976 Mio. USD und der verwässerte EPS 1,60 USD.
Nach dem Spin-off von Holcim im Juni 2025 hat Amrize seine Kapitalstruktur neu gestaltet: Langfristige Verbindlichkeiten betrugen 4.932 Mio. USD, einschließlich neuer Senior Notes, die zu Beginn 2025 ausgegeben und ausgetauscht wurden, sowie umlaufendes Commercial Paper im Wert von 547 Mio. USD. Die Cash and Cash Equivalents beliefen sich auf 826 Mio. USD. Der operative Cashflow für die neun Monate betrug 404 Mio. USD, mit Investitionen in Sachanlagen von 631 Mio. USD. Die Anzahl der ausstehenden Aktien betrug zum 30. September 2025 553.082.069.
أعلنت Amrize Ltd (AMRZ) عن نتائج الربع الثالث من 2025. ارتفع الإيرادات إلى 3,675 مليون دولار من 3,446 مليون دولار، بينما كان الربح المخفف للسهم 0.98 دولار مقابل 1.00 دولار في العام السابق. تحسن الربح الإجمالي إلى 1,086 مليون دولار، لكن دخل التشغيل انخفض إلى 778 مليون دولار مع زيادة المصروفات البيعية، العامة والإدارية إلى 312 مليون دولار.
على مستوى الأقسام، بلغت إيرادات Building Materials 2,774 مليون دولار مع EBITDA معدل حسب القطاع قدره 902 مليون دولار، وبلغت إيرادات Building Envelope 901 مليون دولار مع EBITDA معدل حسب القطاع قدره 217 مليون دولار. خلال التسعة شهور الأولى، بلغ الإيراد 8,976 مليون دولار وربح السهم المخفف 1.60 دولار.
بعد فك الارتباط عن Holcim في يونيو 2025، أعادت Amrize هيكلة رأس مالها: كان الدين طويل الأجل 4,932 مليون دولار، بما في ذلك السندات الجديدة ذات الأولوية التي أُصدِرت في مطلع 2025 والسندات القابلة للمبادلة، والورقة التجارية المتداولة بقيمة 547 مليون دولار. بلغت النقدية وما يعادلها 826 مليون دولار. بلغ التدفق النقدي التشغيلي خلال التسعة أشهر 404 ملايين دولار، مع نفقات رأس المال 631 مليون دولار. بلغ عدد الأسهم المصدرة حتى 30 سبتمبر 2025 553,082,069 سهماً.
- None.
- None.
Insights
Revenue grew, margins tightened; leverage reset post spin-off.
Amrize posted Q3 revenue of 
The capital structure changed materially after the spin-off. Long-term debt totaled 
Nine-month operating cash flow was 
Amrize Ltd (AMRZ) ha riportato i risultati del Q3 2025. Le entrate sono aumentate a 3.675 milioni di dollari da 3.446 milioni, mentre l'EPS diluito è stato 0,98 dollari contro 1,00 dollaro dell'anno precedente. Il profitto lordo è migliorato a 1.086 milioni, ma l'utile operativo è diminuito a 778 milioni poiché le spese di vendita, generali e amministrative sono aumentate a 312 milioni.
Per segmento, le entrate dei Building Materials sono state 2.774 milioni con EBITDA rettificato di segmento di 902 milioni, e le entrate del Building Envelope sono state 901 milioni con EBITDA rettificato di segmento di 217 milioni. Nei primi nove mesi, le entrate sono state 8.976 milioni e l'EPS diluito è stato 1,60.
Dopo lo spin-off da Holcim avvenuto nel giugno 2025, Amrize ha ristrutturato la propria struttura del capitale: il debito a lungo termine ammontava a 4.932 milioni, inclusi i nuovi senior notes emessi all'inizio del 2025 e note scambiate, e carta commerciale in circolazione per 547 milioni. La cassa e gli equivalenti di cassa ammontavano a 826 milioni. Il flusso di cassa operativo nei nove mesi è stato di 404 milioni, con investimenti in capitale di 631 milioni. Le azioni in circolazione ammontavano a 553.082.069 al 30 settembre 2025.
Amrize Ltd (AMRZ) informó resultados del tercer trimestre de 2025. Los ingresos aumentaron a 3.675 millones de dólares desde 3.446 millones, mientras que el BPA diluido fue de 0,98 dólares frente a 1,00 dólar hace un año. El beneficio bruto mejoró a 1.086 millones, pero el ingreso operativo disminuyó a 778 millones ya que los gastos de venta, generales y administrativos aumentaron a 312 millones.
Por segmento, los ingresos de Building Materials fueron de 2.774 millones con EBITDA ajustado por segmento de 902 millones, y los ingresos de Building Envelope fueron de 901 millones con EBITDA ajustado por segmento de 217 millones. En los primeros nueve meses, los ingresos fueron de 8.976 millones y el BPA diluido fue de 1,60.
Tras su spin-off de Holcim en junio de 2025, Amrize reestructuró su estructura de capital: la deuda a largo plazo fue de 4.932 millones, incluyendo las nuevas notas senior emitidas a principios de 2025 y notas canjeadas, y el papel comercial en circulación de 547 millones. La liquidez en caja y equivalentes fue de 826 millones. El flujo de efectivo operativo de los nueve meses fue de 404 millones, con gastos de capital de 631 millones. Las acciones en circulación eran 553.082.069 al 30 de septiembre de 2025.
Amrize Ltd (AMRZ)가 2025년 3분기 실적을 발표했습니다. 매출은 3,675백만 달러에서 3,446백만 달러에서 증가했고, 희석된 주당순이익(EPS)은 지난해 같은 기간의 1.00달러에서 0.98달러로 감소했습니다. 총이익은 1,086백만원으로 개선되었으나 영업이익은 778백만원으로 감소했고 매출원가 및 일반관리비가 312백만원 상승했습니다.
섹터별로 Building Materials 매출은 2,774백만 달러, 세그먼트 조정 EBITDA는 902백만 달러였고, Building Envelope 매출은 901백만 달러로 세그먼트 조정 EBITDA는 217백만 달러였습니다. 처음 9개월 동안 매출은 8,976백만 달러였고 희석된 EPS는 1.60달러였습니다.
2025년 6월 Holcim으로부터의 분사 이후, Amrize는 자본구조를 재구성했습니다: 장기부채는 4,932백만 달러였으며, 2025년 초에 발행된 신규 상환우선채 및 교환채, 그리고 유통 중인 상업어음 54.7백만 달러가 포함되었습니다. 현금 및 현금성자산은 8.26억 달러였습니다. 9개월간 영업활동현금흐름은 4.04억 달러, 자본지출은 6.31억 달러였습니다. 2025년 9월 30일 기준 발행주식수는 5억 5,308만 2,069주였습니다.
Amrize Ltd (AMRZ) a publié ses résultats du T3 2025. Le chiffre d'affaires a augmenté à 3 675 millions de dollars contre 3 446 millions, tandis que le BPA dilué était de 0,98 dollar contre 1,00 dollar l'an dernier. La marge brute s'est améliorée à 1 086 millions, mais le résultat opérationnel a diminué à 778 millions, les dépenses de vente, générales et administratives augmentant à 312 millions.
Par segment, le chiffre d'affaires Building Materials était de 2 774 millions, avec un EBITDA ajusté par segment de 902 millions, et le chiffre d'affaires Building Envelope était de 901 millions, avec un EBITDA ajusté par segment de 217 millions. Pour les neuf premiers mois, le chiffre d'affaires était de 8 976 millions et le BPA dilué était de 1,60.
Suite à sa scission de Holcim en juin 2025, Amrize a restructuré sa structure de capital: la dette à long terme était de 4 932 millions, incluant les nouvelles obligations senior émises au début de 2025 et des notes échangées, et le papier commercial en circulation de 547 millions. La trésorerie et les équivalents de trésorerie s'élevaient à 826 millions. Le flux de trésorerie opérationnel sur neuf mois était de 404 millions, avec des dépenses d'investissement de 631 millions. Le nombre d'actions en circulation était de 553 082 069 au 30 septembre 2025.
Amrize Ltd (AMRZ) meldete die Ergebnisse für das Q3 2025. Der Umsatz stieg auf 3.675 Mio. USD von 3.446 Mio. USD, während der verwässerte Gewinn je Aktie (EPS) 0,98 USD betrug gegenüber 1,00 USD im Vorjahr. Die Bruttogewinnmarge verbesserte sich auf 1.086 Mio. USD, aber das Operating Income ging auf 778 Mio. USD zurück, da die Vertriebs-, Allgemeine und Verwaltungskosten auf 312 Mio. USD stiegen.
Nach Segmenten betrachtet, belief sich der Umsatz von Building Materials auf 2.774 Mio. USD mit einem segmentbezogenen EBITDA von 902 Mio. USD, und der Umsatz von Building Envelope betrug 901 Mio. USD mit einem segmentbezogenen EBITDA von 217 Mio. USD. In den ersten neun Monaten betrug der Umsatz 8.976 Mio. USD und der verwässerte EPS 1,60 USD.
Nach dem Spin-off von Holcim im Juni 2025 hat Amrize seine Kapitalstruktur neu gestaltet: Langfristige Verbindlichkeiten betrugen 4.932 Mio. USD, einschließlich neuer Senior Notes, die zu Beginn 2025 ausgegeben und ausgetauscht wurden, sowie umlaufendes Commercial Paper im Wert von 547 Mio. USD. Die Cash and Cash Equivalents beliefen sich auf 826 Mio. USD. Der operative Cashflow für die neun Monate betrug 404 Mio. USD, mit Investitionen in Sachanlagen von 631 Mio. USD. Die Anzahl der ausstehenden Aktien betrug zum 30. September 2025 553.082.069.
أعلنت Amrize Ltd (AMRZ) عن نتائج الربع الثالث من 2025. ارتفع الإيرادات إلى 3,675 مليون دولار من 3,446 مليون دولار، بينما كان الربح المخفف للسهم 0.98 دولار مقابل 1.00 دولار في العام السابق. تحسن الربح الإجمالي إلى 1,086 مليون دولار، لكن دخل التشغيل انخفض إلى 778 مليون دولار مع زيادة المصروفات البيعية، العامة والإدارية إلى 312 مليون دولار.
على مستوى الأقسام، بلغت إيرادات Building Materials 2,774 مليون دولار مع EBITDA معدل حسب القطاع قدره 902 مليون دولار، وبلغت إيرادات Building Envelope 901 مليون دولار مع EBITDA معدل حسب القطاع قدره 217 مليون دولار. خلال التسعة شهور الأولى، بلغ الإيراد 8,976 مليون دولار وربح السهم المخفف 1.60 دولار.
بعد فك الارتباط عن Holcim في يونيو 2025، أعادت Amrize هيكلة رأس مالها: كان الدين طويل الأجل 4,932 مليون دولار، بما في ذلك السندات الجديدة ذات الأولوية التي أُصدِرت في مطلع 2025 والسندات القابلة للمبادلة، والورقة التجارية المتداولة بقيمة 547 مليون دولار. بلغت النقدية وما يعادلها 826 مليون دولار. بلغ التدفق النقدي التشغيلي خلال التسعة أشهر 404 ملايين دولار، مع نفقات رأس المال 631 مليون دولار. بلغ عدد الأسهم المصدرة حتى 30 سبتمبر 2025 553,082,069 سهماً.
Amrize Ltd (AMRZ) 公布了 2025 年第三季度业绩。 收入从 34.46 亿美元增至 36.75 亿美元,稀释后每股收益为 0.98 美元,而去年同期为 1.00 美元。毛利润提升至 10.86 亿美元,但经营利润下降至 7.78 亿美元,因为销售、一般及管理费用增加至 3.12 亿美元。
按细分市场,建筑材料(Building Materials)收入为 27.74 亿美元,细分板块调整后 EBITDA 为 9.02 亿美元;建筑围护(Building Envelope)收入为 9.01 亿美元,细分板块调整后 EBITDA 为 2.17 亿美元。前九个月的收入为 89.76 亿美元,稀释后每股收益为 1.60 美元。
在 2025 年 6 月从 Holcim 分拆后,Amrize 重塑了资本结构:长期债务为 49.32 亿美元,其中包括 2025 年初发行的新高级票据和置换票据,以及流通中的商业票据 5.47 亿美元。现金及现金等价物为 8.26 亿美元。九个月的经营现金流为 4.04 亿美元,资本支出为 6.31 亿美元。截至 2025 年 9 月 30 日,流通在外的股本为 553,082,069 股。
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES EXCHANGE ACT OF 1934 | 
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES EXCHANGE ACT OF 1934 | 
| (State or Other Jurisdiction of Incorporation or  Organization) | (I.R.S. Employer Identification No.) | 
| 6300 | |||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||
| Title of each class | Trading symbols(s) | Name of exchange on which registered | 
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |
| ☒ | Smaller reporting company | |||
| Emerging growth company | 
| PART I - FINANCIAL INFORMATION | 4 | 
| Item 1. Financial Statements | 4 | 
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 37 | 
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 53 | 
| Item 4. Controls and Procedures | 54 | 
| PART II - OTHER INFORMATION | 56 | 
| Item 1. Legal Proceedings | 56 | 
| Item 1A. Risk Factors | 56 | 
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 56 | 
| Item 3. Defaults Upon Senior Securities | 56 | 
| Item 4. Mine Safety Disclosures | 56 | 
| Item 5. Other Information | 56 | 
| Item 6. Exhibits | 57 | 
| Signatures | 58 | 
| For the three months ended  September 30, | For the nine months ended  September 30,  | ||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||
| Revenues | $ | $ | $ | $ | |||||
| Cost of revenues | ( | ( | ( | ( | |||||
| Gross profit | |||||||||
| Selling, general and administrative expenses | ( | ( | ( | ( | |||||
| Gain on disposal of long-lived assets | |||||||||
| Loss on impairments | ( | ( | |||||||
| Operating income | |||||||||
| Interest expense, net | ( | ( | ( | ( | |||||
| Other non-operating (expense) income, net | ( | ( | |||||||
| Income before income tax expense and income from  equity method investments | |||||||||
| Income tax expense | ( | ( | ( | ( | |||||
| Income from equity method investments | |||||||||
| Net income | |||||||||
| Net loss attributable to noncontrolling interests | |||||||||
| Net income attributable to the Company | $ | $ | $ | $ | |||||
| Earnings per share attributable to the Company: | |||||||||
| Basic | $ | $ | $ | $ | |||||
| Diluted | $ | $ | $ | $ | |||||
| Weighted-average number of shares outstanding: | |||||||||
| Basic | |||||||||
| Diluted | |||||||||
| For the three months ended  September 30, | For the nine months ended  September 30,  | ||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||
| Comprehensive income: | |||||||||
| Net income | $ | $ | $ | $ | |||||
| Other comprehensive (loss) income, net of tax: | |||||||||
| Foreign currency translation | ( | ( | |||||||
| Net change in fair value of cash flow hedges, net of  tax | ( | ||||||||
| Actuarial (losses) gains and prior service (costs)  credits for defined benefit pension plans and other  postretirement benefit plans, net of tax   | ( | ( | ( | ||||||
| Total other comprehensive (loss) income, net of  tax | ( | ( | |||||||
| Total comprehensive income | $ | $ | $ | $ | |||||
| Comprehensive loss attributable to noncontrolling  interests | |||||||||
| Comprehensive income attributable to the Company | $ | $ | $ | $ | |||||
| As of | As of | |||
| September 30, 2025 | December 31, 2024 | |||
| Assets | ||||
| Current Assets: | ||||
| Cash and cash equivalents | $ | $ | ||
| Accounts receivable, net | ||||
| Due from related-party | ||||
| Inventories | ||||
| Related-party notes receivable | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Property, plant and equipment, net | ||||
| Goodwill | ||||
| Intangible assets, net | ||||
| Operating lease right-of-use assets, net | ||||
| Other noncurrent assets | ||||
| Total Assets | $ | $ | ||
| Liabilities and Equity | ||||
| Current Liabilities: | ||||
| Accounts payable | $ | $ | ||
| Short-term borrowings | ||||
| Due to related-party | ||||
| Current portion of long-term debt | ||||
| Current portion of related-party notes payable | ||||
| Operating lease liabilities | ||||
| Other current liabilities | ||||
| Total current liabilities | ||||
| Long-term debt | ||||
| Related-party notes payable | ||||
| Deferred income tax liabilities | ||||
| Noncurrent operating lease liabilities | ||||
| Other noncurrent liabilities | ||||
| Total Liabilities | ||||
| Commitments and contingencies (see Note 17) | ||||
| Equity: | ||||
| Common stock, par value of $ authorized,  as of September 30, 2025 | ||||
| Additional paid-in capital | ||||
| Retained earnings | ||||
| Net parent investment | ||||
| Treasury stock,  | ||||
| Accumulated other comprehensive loss | ( | ( | ||
| Total Equity attributable to the Company | ||||
| Noncontrolling interests | ( | ( | ||
| Total Equity | ||||
| Total Liabilities and Equity | $ | $ | 
| For the nine months ended September 30,  | ||||
| 2025 | 2024 | |||
| Cash flows from operating activities: | ||||
| Net income | $ | $ | ||
| Adjustments to reconcile net income to net cash provided by operating  activities: | ||||
| Depreciation, depletion, accretion and amortization | ||||
| Share-based compensation | ||||
| Gain on disposal of long-lived assets  | ( | ( | ||
| Gain on land expropriation | ( | |||
| Deferred tax expense | ||||
| Net periodic pension benefit cost | ||||
| Other items, net | ||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | ||||
| Accounts receivable, net | ( | ( | ||
| Due from related-party | ( | |||
| Inventories | ( | ( | ||
| Accounts payable | ( | |||
| Due to related-party | ( | |||
| Other assets | ( | ( | ||
| Other liabilities | ( | ( | ||
| Defined benefit pension plans and other postretirement benefit plans | ( | ( | ||
| Net cash provided by operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchases of property, plant and equipment | ( | ( | ||
| Acquisitions, net of cash acquired | ( | ( | ||
| Proceeds from disposals of long-lived assets | ||||
| Proceeds from land expropriation | ||||
| Proceeds from property and casualty insurance | ||||
| Net decrease (increase) in short-term related-party notes receivable  from cash pooling program  | ( | |||
| Other investing activities, net | ( | ( | ||
| Net cash used in investing activities | ( | ( | ||
| Cash flows from financing activities: | ||||
| Transfers to Parent, net  | ( | ( | ||
| Proceeds from short-term borrowings, net | ||||
| Proceeds from issuance of long-term debt, net of discount | ||||
| Payments of debt issuance costs | ( | |||
| Net (repayments) proceeds of short-term related-party debt | ( | ( | ||
| Proceeds from debt-for-debt exchange with Parent | ||||
| Proceeds from issuances of long-term related-party debt | ||||
| Repayments of long-term related-party debt | ( | ( | ||
| Payments of finance lease obligations | ( | ( | ||
| Other financing activities, net | ( | ( | ||
| Net cash used in financing activities | ( | ( | ||
| Effect of exchange rate changes on cash and cash equivalents | ( | |||
| Decrease in cash and cash equivalents | ( | ( | ||
| Cash and cash equivalents at the beginning of period | ||||
| Cash and cash equivalents at the end of period | $ | $ | ||
| Common stock | Treasury stock | |||||||||
| Shares | Amount | Shares | Amount | Additional  paid-in  capital | Retained  earnings | Net parent  investment | Accumulated  other  comprehensive  loss | Equity  attributable to  noncontrolling  interests | Total  equity | |
| Balance as of  June 30, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
| Net income  (loss) | — | — | — | — | — | — | — | ( | ||
| Other  comprehensive  loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( | 
| Share-based  compensation  expense and  other | — | — | — | — | ( | — | — | — | ||
| Balance as of  September 30,  2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
| Common stock | Treasury stock | |||||||||
| Shares | Amount | Shares | Amount | Additional  paid-in  capital | Retained  earnings | Net parent  investment | Accumulated  other  comprehensive  loss | Equity  attributable to  noncontrolling  interests | Total  equity | |
| Balance as of  June 30, 2024 | $ | $ | $ | $ | $ | $( | $( | $ | ||
| Net income  (loss) | — | — | — | — | — | — | — | ( | ||
| Other  comprehensive  income, net of  taxes | — | — | — | — | — | — | — | — | ||
| Net transfers to  Parent | — | — | — | — | — | — | ( | — | — | ( | 
| Balance as of  September 30,  2024 | $ | $ | $ | $ | $ | $( | $( | $ | ||
| Common stock | Treasury stock | |||||||||
| Shares | Amount | Shares | Amount | Additional  paid-in  capital | Retained  earnings | Net parent  investment | Accumulated  other  comprehensive  loss | Equity  attributable to  noncontrolling  interests | Total  equity | |
| Balance as of  December 31,  2024 | $ | $ | $ | $ | $ | $( | $( | $ | ||
| Net income  (loss) | — | — | — | — | — | — | ( | |||
| Other  comprehensive  income, net of  taxes | — | — | — | — | — | — | — | — | ||
| Changes in  equity  attributable to  noncontrolling  interests | — | — | — | — | — | — | ( | — | ||
| Net transfers  from Parent  including Spin- off-related  adjustments | — | — | — | — | — | — | — | |||
| Issuance of  Common stock,  Treasury stock  and  reclassification  of Net parent  investment | ( | — | — | ( | — | — | ||||
| Share-based  compensation  expense and  other | — | — | — | — | ( | — | — | — | ||
| Balance as of  September 30,  2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
| Common stock | Treasury stock | |||||||||
| Shares | Amount | Shares | Amount | Additional  paid-in  capital | Retained  earnings | Net parent  investment | Accumulated  other  comprehensive  loss | Equity  attributable to  noncontrolling  interests | Total  equity | |
| Balance as of  December 31,  2023 | $ | $ | $ | $ | $ | $( | $ | $ | ||
| Net income  (loss) | — | — | — | — | — | — | — | ( | ||
| Other  comprehensive  loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( | 
| Net transfers to  Parent | — | — | — | — | — | — | ( | — | — | ( | 
| Balance as of  September 30,  2024 | $ | $ | $ | $ | $ | $( | $( | $ | ||
| For the three months ended  September 30, | For the nine months ended  September 30,  | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Building Materials | |||||||||
| Cement | $ | $ | $ | $ | |||||
| Aggregates and other construction materials | |||||||||
| Interproduct revenues | ( | ( | ( | ( | |||||
| Building Envelope | |||||||||
| Total Revenues | $ | $ | $ | $ | |||||
| (In millions) | 2025 | 2024 | ||
| Balance as of January 1 | $ | $ | ||
| Revenue recognized | ( | ( | ||
| Revenue deferred | ||||
| Balance as of September 30 | $ | $ | 
| (In millions) | Total 2025 Acquisitions | ||
| Total consideration | $ | ||
| Total Assets and Liabilities Acquired | |||
| Inventories, net | |||
| Property, plant and equipment, net | |||
| Intangible assets | |||
| Debt assumed | ( | ||
| Net working capital | ( | ||
| Total identifiable net assets at fair value | |||
| Goodwill | |||
| Total estimated fair value of net assets | |||
| Less: fair value of previously held equity method investment | ( | ||
| Net consideration | $ | ||
| Acquisitions of business, net of cash acquired | |||
| Cash consideration | |||
| Less: cash and cash equivalents acquired | ( | ||
| Total outflow in the statement of cash flows | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Trade receivables | $ | $ | ||
| Less: allowance for credit losses | ( | ( | ||
| Other current receivables, net | ||||
| Accounts receivable, net | $ | $ | 
| (In millions) | 2025 | 2024 | ||
| Balance as of January 1 | $ | $ | ||
| Charge-offs | ( | ( | ||
| Provision for credit losses | ||||
| Foreign currency translation and other | ( | |||
| Balance as of September 30 | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Raw materials, parts, and supplies | $ | $ | ||
| Semi-finished and finished goods | ||||
| Total Inventories | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Land and mineral reserves | $ | $ | ||
| Buildings and installations | ||||
| Machines, furniture, vehicles and tools | ||||
| Construction in progress | ||||
| Finance lease right-of-use assets | ||||
| Total property, plant and equipment | ||||
| Less: accumulated depreciation, depletion and impairment | ( | ( | ||
| Property, plant and equipment, net | $ | $ | 
| (In millions) | Building Materials | Building Envelope | Total | |||
| Balance as of December 31, 2024 | $ | $ | $ | |||
| Acquisitions | ||||||
| Foreign currency translation adjustment and  other(1) | ||||||
| Balance as of September 30, 2025 | $ | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Prepaid expenses | $ | $ | ||
| Contract assets | ||||
| Other | ||||
| Total Prepaid expenses and other current assets | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Equity method investments | $ | $ | ||
| Advanced payments to suppliers(1) | ||||
| Contract assets | ||||
| Other | ||||
| Total Other noncurrent assets | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Finance lease liabilities | $ | $ | ||
| Income tax payable | ||||
| Employee-related liabilities other than pension | ||||
| Short-term provisions | ||||
| Contract liabilities | ||||
| Asset retirement obligations | ||||
| Pension liabilities | ||||
| Accrued purchases of property, plant and equipment | ||||
| Self-insurance reserves | ||||
| Accrued interest | ||||
| Other(1) | ||||
| Total Other current liabilities | $ | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Liabilities for unrecognized tax benefits | $ | $ | ||
| Finance lease liabilities | ||||
| Asset retirement obligations | ||||
| Pension liabilities | ||||
| Contract liabilities | ||||
| Environmental remediation liabilities | ||||
| Self-insurance reserves | ||||
| Other(1) | ||||
| Total Other noncurrent liabilities | $ | $ | 
| Effective interest rate  as of September 30,  | Balance as of  September 30,  | Balance as of  December 31,  | ||||
| (In millions) | 2025 | 2025 | 2024 | |||
| $ | $ | |||||
| Other | ||||||
| Total principal | ||||||
| Unamortized discounts, premiums and debt issuance  costs | ( | |||||
| Total long-term debt | ||||||
| Less: current portion of long-term debt | ( | ( | ||||
| Long-term debt | $ | $ | 
| (In millions) | As of September 30, 2025 | |
| Carrying amount | $ | |
| Fair value | $ | 
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Operating lease right-of-use assets, net | $ | $ | ||
| Finance lease right-of-use assets, net | ||||
| Total lease assets, net | $ | $ | ||
| Current portion of operating lease liabilities | ||||
| Current portion of finance lease liabilities | ||||
| Noncurrent portion of operating lease liabilities | ||||
| Noncurrent portion of finance lease liabilities | ||||
| Total lease liabilities | $ | $ | 
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Operating lease expense | $ | $ | $ | $ | |||||
| Finance lease expense | |||||||||
|   Amortization of leased assets | |||||||||
|   Interest on lease liabilities | |||||||||
| Short term lease cost | |||||||||
| Variable lease cost | |||||||||
| Total lease expense | $ | $ | $ | $ | |||||
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Accretion | $ | $ | $ | $ | |||||
| Depreciation | |||||||||
| Total costs | $ | $ | $ | $ | |||||
| (In millions) | 2025 | |
| Balance as of January 1 | $ | |
| Accretion expense | ||
| Liabilities incurred and acquired | ||
| Liabilities settled | ( | |
| Foreign currency translation adjustment | ||
| Balance as of September 30 | $ | 
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions, except for percentage data) | 2025 | 2024 | 2025 | 2024 | |||||
| Total tax expense | $ | $ | $ | $ | |||||
| Effective income tax rate | |||||||||
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Revenues: | |||||||||
| Building Materials | $ | $ | $ | $ | |||||
| Building Envelope | |||||||||
| Total Revenues | $ | $ | $ | $ | |||||
| Cost of revenues: | |||||||||
| Building Materials | $ | $ | $ | $ | |||||
| Building Envelope | |||||||||
| Total cost of revenues | $ | $ | $ | $ | |||||
| Other segment expenses(1): | |||||||||
| Building Materials | $ | $ | $ | $ | |||||
| Building Envelope | |||||||||
| Total other segment expenses | $ | $ | $ | $ | |||||
| Segment Adjusted EBITDA: | |||||||||
| Building Materials | $ | $ | $ | $ | |||||
| Building Envelope | |||||||||
| Total Segment Adjusted EBITDA | $ | $ | $ | $ | |||||
| Reconciling items: | |||||||||
|   Depreciation, depletion, accretion and amortization | ( | ( | ( | ( | |||||
|   Loss on impairments | ( | ( | |||||||
|   Unallocated corporate costs | ( | ( | ( | ( | |||||
|   Acquisition and integration costs(2) | ( | ( | ( | ( | |||||
|   Litigation related costs | ( | ( | ( | ( | |||||
|   Spin-off and separation-related costs(3) | ( | ( | ( | ( | |||||
|   Restructuring and other costs | ( | ( | ( | ( | |||||
|   Interest income | |||||||||
|   Interest expense | ( | ( | ( | ( | |||||
|   Other non-operating (expense) income, net | ( | ( | |||||||
| Total reconciling items | $( | $( | $( | $( | |||||
| Income before income tax expense and income from  equity method investments: | $ | $ | $ | $ | |||||
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Capital expenditures(1): | |||||||||
| Building Materials | $ | $ | $ | $ | |||||
| Building Envelope | |||||||||
| Total capital expenditures | $ | $ | $ | $ | |||||
| As of | As of | |||
| (In millions) | September 30, 2025 | December 31, 2024 | ||
| Segment assets(1): | ||||
| Building Materials | $ | $ | ||
| Building Envelope | ||||
| Total segment assets | ||||
| Other assets | ||||
| Total assets | $ | $ | 
| For the three months ended September 30,  | |||||||||
| Defined Benefit Pension Plans | |||||||||
| U.S. | Non-U.S. | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Components of Net periodic pension benefit  | |||||||||
| Service cost | $ | $ | $ | $ | |||||
| Interest cost | |||||||||
| Expected return on assets | ( | ( | |||||||
| Amortization of actuarial gain | ( | ||||||||
| Settlement loss | |||||||||
| Net periodic pension benefit cost  | $ | $ | $ | $ | |||||
| For the nine months ended September 30,  | |||||||||
| Defined Benefit Pension Plans | |||||||||
| U.S. | Non-U.S. | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Components of Net periodic pension benefit  | |||||||||
| Service cost | $ | $ | $ | $ | |||||
| Interest cost | |||||||||
| Expected return on assets | ( | ( | |||||||
| Amortization of actuarial gain | ( | ||||||||
| Settlement loss | |||||||||
| Net periodic pension benefit cost  | $ | $ | $ | $ | |||||
| For the three months ended September 30,  | |||||||||
| Other Postretirement Benefit Plans | |||||||||
| U.S. | Non-U.S. | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Components of Net periodic pension benefit  | |||||||||
| Service cost | $ | $ | $ | $ | |||||
| Interest cost | |||||||||
| Amortization of actuarial gain | ( | ( | |||||||
| Net periodic pension benefit cost | $ | $ | $ | $ | |||||
| For the nine months ended September 30,  | |||||||||
| Other Postretirement Benefit Plans | |||||||||
| U.S. | Non-U.S. | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Components of Net periodic pension benefit  | |||||||||
| Service cost | $ | $ | $ | $ | |||||
| Interest cost | |||||||||
| Amortization of actuarial gain | ( | ( | ( | ||||||
| Net periodic pension benefit cost | $ | $ | $ | $ | |||||
| (In millions) | Foreign Currency  Translation  Adjustment | Cash Flow Hedges | Defined Benefit  Pension and  Other  Postretirement  Benefit Plans | Total | ||||
| Balance as of June 30, 2025 | $( | $ | $ | $( | ||||
| Other comprehensive (loss) income before  reclassifications | ( | ( | ||||||
| Amounts reclassified from Accumulated  other comprehensive loss to Net income | ( | ( | ||||||
| Net current-period Other comprehensive  (loss) income | ( | ( | ||||||
| Other comprehensive loss attributable to  noncontrolling interests | ||||||||
| Balance as of September 30, 2025 | $( | $ | $ | $( | ||||
| Balance as of June 30, 2024 | $( | $( | $( | $( | ||||
| Other comprehensive income (loss) before  reclassifications | ( | |||||||
| Amounts reclassified from Accumulated  other comprehensive loss to Net income | ( | |||||||
| Net current-period Other comprehensive  income (loss) | ( | ( | ||||||
| Balance as of September 30, 2024 | $( | $( | $( | $( | 
| (In millions) | Foreign Currency  Translation  Adjustment | Cash Flow Hedges | Defined Benefit  Pension and  Other  Postretirement  Benefit Plans | Total | ||||
| Balance as of December 31, 2024 | $( | $( | $ | $( | ||||
| Other comprehensive income (loss) before  reclassifications | ||||||||
| Amounts reclassified from Accumulated  other comprehensive loss to Net income | ( | ( | ( | |||||
| Net current-period Other comprehensive  income (loss) | ( | |||||||
| Unrecognized gain transferred from  Parent pension | — | — | ||||||
| Balance as of September 30, 2025 | $( | $ | $ | $( | ||||
| Balance as of December 31, 2023 | $( | $( | $( | $( | ||||
| Other comprehensive (loss) income before  reclassifications | ( | ( | ( | |||||
| Amounts reclassified from Accumulated  other comprehensive loss to Net income | ( | |||||||
| Net current-period Other comprehensive  (loss) income | ( | ( | ( | |||||
| Balance as of September 30, 2024 | $( | $( | $( | $( | 
| For the three months ended  September 30, | For the nine months ended  September 30, | ||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||
| Net change in fair value of effective portion of  cash flow hedges | |||||||||
| Cost of revenues | $( | $( | $( | $( | |||||
| Income tax expense (benefit) | ( | ( | |||||||
| Total | $( | $( | $( | $( | |||||
| Actuarial losses and prior service costs for  defined benefit pension plans and other  postretirement benefit plans | |||||||||
| Other non-operating income, net | $( | $ | $( | $ | |||||
| Income tax expense (benefit) | ( | ( | |||||||
| Total | $ | $ | $( | $ | |||||
| Total amounts reclassified from Accumulated  other comprehensive income (loss) to Net income | $( | $ | $( | $ | |||||
| (In millions) | 2025 | 2024 | ||
| Balance as of January 1 | $ | $ | ||
| Increase for warranties issued | ||||
| Increase for pre-existing warranties | ||||
| Decrease for payments | ( | ( | ||
| Balance as of September 30 | $ | $ | 
| For the three months  ended September 30,  | For the nine months ended  September 30,  | |||||
| (In millions) | 2024 | 2025 | 2024 | |||
| Cost of revenues | $ | $ | $ | |||
| Selling, general and administrative expenses | ||||||
| Total | $ | $ | $ | |||
| For the nine months ended September 30,  | ||||||
| (In millions) | 2025 | 2024 | ||||
| Net transfers to Parent as reflected on the unaudited condensed  consolidated statements of cash flows (1) | $( | $( | ||||
| Equity contribution from Parent related to the settlement of Related-party  notes payable | ||||||
| Other non-cash activities with Parent, net(2) | ||||||
| Net transfers (to) from Parent as reflected on the unaudited  condensed consolidated statements of equity | $ | $( | ||||
| For the nine months ended September 30,  | ||||
| (In millions) | 2025 | 2024 | ||
| Interest paid | $ | $ | ||
| Income taxes paid | ||||
| Operating cash flows used for operating leases | ( | ( | ||
| Operating cash flows used for finance leases | ( | ( | ||
| Financing cash flows used for finance leases | ( | ( | ||
| For the nine months ended September 30,  | ||||
| (In millions) | 2025 | 2024 | ||
| Accrued purchases of property, plant and equipment | $ | $ | ||
| Right-of-use assets obtained in exchange for new operating lease  liabilities | ||||
| Right-of-use assets obtained in exchange for new finance lease liabilities | ||||
| Equity contribution from Parent related to the settlement of Related-party  notes payable | ||||
| Debt assumed in connection with a business combination | ||||
| For the three months ended  September 30,  | For the nine months ended  September 30,  | ||||||||
| (In millions, except per share data) | 2025 | 2024 | 2025 | 2024 | |||||
| Numerator: | |||||||||
| Net income | $ | $ | $ | $ | |||||
| Net loss attributable to noncontrolling  interest | |||||||||
| Net income attributable to the Company | $ | $ | $ | $ | |||||
| Denominator: | |||||||||
| Basic weighted-average number of shares  outstanding | |||||||||
| Dilutive effect of share-based awards | |||||||||
| Diluted weighted-average number of shares  outstanding | |||||||||
| Earnings per share | |||||||||
| Basic | $ | $ | $ | $ | |||||
| Diluted | $ | $ | $ | $ | |||||
| For the three months ended September 30,  | For the nine months ended September 30,  | |||||||||||
| (In millions, except for percentage data) | 2025 | 2024 | % change | 2025 | 2024 | % change | ||||||
| Revenues | $3,675 | $3,446 | 6.6% | $8,976 | $8,855 | 1.4% | ||||||
| Cost of revenues | (2,589) | (2,404) | 7.7% | (6,702) | (6,562) | 2.1% | ||||||
| Gross profit | 1,086 | 1,042 | 4.2% | 2,274 | 2,293 | (0.8)% | ||||||
| Selling, general and administrative  expenses | (312) | (241) | 29.5% | (850) | (682) | 24.6% | ||||||
| Gain on disposal of long-lived  assets | 4 | 43 | (90.7)% | 9 | 49 | (81.6)% | ||||||
| Loss on impairments | — | — | —% | (2) | (2) | —% | ||||||
| Operating income | 778 | 844 | (7.8)% | 1,431 | 1,658 | (13.7)% | ||||||
| Interest expense, net | (89) | (130) | (31.5)% | (328) | (384) | (14.6)% | ||||||
| Other non-operating (expense)  income, net | — | (11) | (100.0)% | 2 | (7) | (128.6)% | ||||||
| Income before income tax expense and  income from equity method  investments | 689 | 703 | (2.0)% | 1,105 | 1,267 | (12.8)% | ||||||
| Income tax expense | (150) | (155) | (3.2)% | (226) | (293) | (22.9)% | ||||||
| Income from equity method  investments | 4 | 4 | —% | 5 | 7 | (28.6)% | ||||||
| Net income | 543 | 552 | (1.6)% | 884 | 981 | (9.9)% | ||||||
| Net loss attributable to  noncontrolling interests | 2 | 1 | 100.0% | 3 | 2 | 50.0% | ||||||
| Net income attributable to the Company | $545 | $553 | (1.4)% | $887 | $983 | (9.8)% | ||||||
| Adjusted EBITDA(1) | $1,067 | $1,103 | (3.3)% | $2,228 | $2,390 | (6.8)% | ||||||
| Adjusted EBITDA Margin(1) | 29.0% | 32.0% | 24.8% | 27.0% | ||||||||
| Net income margin | 14.8% | 16.0% | 9.8% | 11.1% | ||||||||
| Analysis of Change | ||||||||||||
| (In millions, except for percentage  data) | For the three  months ended  September 30,  2024 | Acquisitions &  Divestments | Organic  Growth | Foreign  Exchange | For the three  months ended  September 30,  2025 | % change | ||||||
| Total Revenues | $3,446 | $38 | $207 | $(16) | $3,675 | 6.6% | ||||||
| Adjusted EBITDA(1) | 1,103 | 7 | (37) | (6) | 1,067 | (3.3)% | ||||||
| Adjusted EBITDA Margin(1) | 32.0% | 29.0% | ||||||||||
| Analysis of Change | ||||||||||||
| (In millions, except for percentage  data) | For the nine  months ended  September 30,  2024 | Acquisitions &  Divestments | Organic  Growth | Foreign  Exchange | For the nine  months ended  September 30,  2025 | % change | ||||||
| Total Revenues | $8,855 | $110 | $66 | $(55) | $8,976 | 1.4% | ||||||
| Adjusted EBITDA(1) | 2,390 | 20 | (167) | (15) | 2,228 | (6.8)% | ||||||
| Adjusted EBITDA Margin(1) | 27.0% | 24.8% | ||||||||||
| For the three months ended September 30,  | For the nine months ended September 30,  | |||||||||||
| (In millions) | 2025 | 2024 | % change | 2025 | 2024 | % change | ||||||
| Segment revenues: | ||||||||||||
| Building Materials(1) | $2,774 | $2,551 | 8.7% | $6,353 | $6,249 | 1.7% | ||||||
| Building Envelope | 901 | 895 | 0.7% | 2,623 | 2,606 | 0.7% | ||||||
| Total revenues | $3,675 | $3,446 | 6.6% | $8,976 | $8,855 | 1.4% | ||||||
| For the three months ended September 30,  | For the nine months ended September 30,  | |||||||||||
| (In millions) | 2025 | 2024 | % change | 2025 | 2024 | % change | ||||||
| Segment Adjusted EBITDA: | ||||||||||||
| Building Materials | $902 | $942 | (4.2)% | $1,780 | $1,886 | (5.6)% | ||||||
| Building Envelope | 217 | 199 | 9.0% | 602 | 600 | 0.3% | ||||||
| Total Segment Adjusted EBITDA | 1,119 | 1,141 | (1.9)% | 2,382 | 2,486 | (4.2)% | ||||||
| Unallocated corporate costs | (52) | (38) | 36.8% | (154) | (96) | 60.4% | ||||||
| Adjusted EBITDA(2) | $1,067 | $1,103 | (3.3)% | $2,228 | $2,390 | (6.8)% | ||||||
| For the three months ended  September 30,  | For the nine months ended  September 30,  | |||||||
| (In millions, except for percentage data) | 2025 | 2024 | 2025 | 2024 | ||||
| Net income | $543 | $552 | $884 | $981 | ||||
| Depreciation, depletion, accretion and amortization | 231 | 228 | 670 | 664 | ||||
| Interest expense, net | 89 | 130 | 328 | 384 | ||||
| Income tax expense | 150 | 155 | 226 | 293 | ||||
| EBITDA | 1,013 | 1,065 | 2,108 | 2,322 | ||||
| Loss on impairments | — | — | 2 | 2 | ||||
| Acquisition and integration costs(1) | 4 | 18 | 33 | 33 | ||||
| Litigation related costs | 40 | 2 | 44 | 3 | ||||
| Spin-off and separation-related costs(2) | 10 | 8 | 35 | 19 | ||||
| Restructuring and other costs | 4 | 3 | 13 | 11 | ||||
| Other non-operating expense (income), net(3) | — | 11 | (2) | 7 | ||||
| Income from equity method investments | (4) | (4) | (5) | (7) | ||||
| Adjusted EBITDA | 1,067 | 1,103 | 2,228 | 2,390 | ||||
| Unallocated corporate costs | 52 | 38 | 154 | 96 | ||||
| Total Segment Adjusted EBITDA | $1,119 | $1,141 | $2,382 | $2,486 | ||||
| Building Materials | 902 | 942 | 1,780 | 1,886 | ||||
| Building Envelope | 217 | 199 | 602 | 600 | ||||
| Net income margin | 14.8% | 16.0% | 9.8% | 11.1% | ||||
| EBITDA Margin | 27.6% | 30.9% | 23.5% | 26.2% | ||||
| Adjusted EBITDA Margin | 29.0% | 32.0% | 24.8% | 27.0% | ||||
| For the nine months ended September 30,  | ||||
| (In millions) | 2025 | 2024 | ||
| Net cash provided by operating activities | $404 | $555 | ||
| Capital expenditures, net(1) | (597) | (493) | ||
| Free cash flow | $(193) | $62 | ||
| Net income | 884 | 981 | ||
| Adjusted EBITDA | 2,228 | 2,390 | ||
| Net income cash conversion ratio |  n/m  |  n/m  | ||
| Adjusted EBITDA cash conversion ratio |  n/m  |  n/m  | ||
| For the nine months ended September 30,  | ||||
|  (In millions) | 2025 | 2024 | ||
| Net cash (used in) provided by: | ||||
| Operating activities  | $404 | $555 | ||
| Investing activities  | (211) | (856) | ||
| Financing activities  | (978) | (374) | ||
| Effect of exchange rate changes on cash and cash equivalents | 26 | (12) | ||
| Increase (decrease) in cash and cash equivalents  | (759) | (687) | ||
| Cash and cash equivalents - beginning of period | 1,585 | 1,107 | ||
| Cash and cash equivalents - end of period | $826 | $420 | ||
| (In millions) | Remainder  of 2025 | 2026 | 2027 | 2028 | 2029 | Thereafter | Total | |||||||
| Principal on  short-term and  long-term debt | $547 | $333 | $700 | $700 | $— | $3,529 | $5,809 | |||||||
| Operating lease  obligations | 44 | 163 | 136 | 105 | 82 | 280 | 810 | |||||||
| Finance lease  obligations | 32 | 115 | 93 | 70 | 45 | 127 | 482 | |||||||
| Pension and  postretirement  contributions | 6 | 24 | 24 | 21 | 21 | 422 | 518 | |||||||
| Purchase  obligations(1) | 509 | 123 | 60 | 53 | 45 | 115 | 905 | |||||||
| Total | $1,138 | $758 | $1,013 | $949 | $193 | $4,473 | $8,524 | 
| Exhibit No. | Exhibit | 
| 31.1* | Certification of CEO, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | 
| 31.2* | Certification of CFO, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | 
| 32.1** | Certification of CEO and CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | 
| 95* | Disclosure of Mine Safety and Health Administration (MSHA) Safety Data | 
| 101* | Inline eXtensible Business Reporting Language (XBRL). | 
| 104 | Cover Page Interactive Data File (formatted in iXBRL in Exhibit 101) | 
| Amrize Ltd | |
| By: | /s/ Ian Johnston | 
| Name: | Ian Johnston | 
| Title: | Chief Financial Officer | 
| (Duly authorized officer and principal financial officer) | |
| Date: | October 29, 2025 | 
 
             
             
             
             
             
             
             
             
         
         
         
        